retatrutide triple agonist gip glp-1 glucagon phase 2 obesity Retatrutide, a (GLP1, GIP, glucagon), just released trial results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Retatrutide: The "Triple G" Peptide
Description
The stability of the analogs is based on their sensitivity to autoxidation, and the moderately stable 7 and 8 degrade slower than curcumin whereas unstable 15 and 16 degrade faster 20
Warren, K
GLP 1 medications (semaglutide, tirzepatide) are incredibly effective and popular
Imagine you struggled with your body weight for years, but overseas, there was a miracle drug pitched as the silver bullet for obesity
The answer is maybe
Retatrutide weight loss results from clinical trials are unlike anything previously recorded for a pharmaceutical treatment
